Non-Current Assets
Other Non-Current Assets
Neurocrine Biosciences Other Non-Current Assets decreased by 66.2% to $20.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.6%, from $22.00M to $20.10M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 56.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2019
Last reportedQ1 2026May 5, 2026
How to read this metric
Significant fluctuations may warrant investigation into the nature of the underlying assets, such as changes in long-term investments or non-core holdings.
Detailed definition
This represents a catch-all category for long-term assets that do not fit into standard classifications like property, p...
Peer comparison
Common in most balance sheets as a residual category for non-material long-term items.
Metric ID:
other_non_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.20M | $3.20M | $4.40M | $10.10M | $10.00M | $10.50M | $25.00M | $24.90M | $35.90M | $13.20M | $49.60M | $12.40M | $18.80M | $23.60M | $52.00M | $22.00M | $21.10M | $20.20M | $59.50M | $20.10M |
| QoQ Change | — | +0.0% | +37.5% | +129.5% | -1.0% | +5.0% | +138.1% | -0.4% | +44.2% | -63.2% | +275.8% | -75.0% | +51.6% | +25.5% | +120.3% | -57.7% | -4.1% | -4.3% | +194.6% | -66.2% |
| YoY Change | — | — | — | — | +212.5% | +228.1% | +468.2% | +146.5% | +259.0% | +25.7% | +98.4% | -50.2% | -47.6% | +78.8% | +4.8% | +77.4% | +12.2% | -14.4% | +14.4% | -8.6% |
Range$3.20M – $59.50M
CAGR+47.2%
Avg YoY Growth+94.1%
Median YoY Growth+51.6%
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's other non-current assets?
- Neurocrine Biosciences (NBIX) reported other non-current assets of $20.10M in Q1 2026.
- How has Neurocrine Biosciences's other non-current assets changed year-over-year?
- Neurocrine Biosciences's other non-current assets decreased by 8.6% year-over-year, from $22.00M to $20.10M.
- What is the long-term trend for Neurocrine Biosciences's other non-current assets?
- Over 5 years (2020 to 2025), Neurocrine Biosciences's other non-current assets has grown at a 56.2% compound annual growth rate (CAGR), from $6.40M to $59.50M.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into major categories like property or investments.